Coventry and Warwickshire’s leading medical negligence practitioners, is offering its professional support to patients ...

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

Allarity Therapeutics has announced a Phase 2 clinical trial to evaluate the combination of stenoparib, a dual PARP/Wnt pathway inhibitor, with temozolomide for patients with recurrent Small Cell ...

Therapeutics announced plans for a Phase 2 trial evaluating the combination of stenoparib with temozolomide, a DNA-alkylating ...

Richard Walker – and another 13 patients – say they were treated with temozolomide for longer than the recommended six months - in Mr Walker's case more than a year longer A brain cancer ...

Orphelia Pharma is exploring alternative regulatory pathways for KIZFIZO after receiving a negative opinion from the ...

The current standard of care for patients with newly diagnosed GBM consists of maximal surgical resection, fractionated radiotherapy with concurrent temozolomide, an oral alkylating ...

Find all the commercial and brand names of generic drug called Temozolomide. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...